These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 16360197)

  • 21. An antithrombin III assay based on factor Xa inhibition provides a more reliable test to identify congenital antithrombin III deficiency than an assay based on thrombin inhibition.
    Demers C; Henderson P; Blajchman MA; Wells MJ; Mitchell L; Johnston M; Ofosu FA; Fernandez-Rachubinski F; Andrew M; Hirsh J
    Thromb Haemost; 1993 Mar; 69(3):231-5. PubMed ID: 8470046
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The influence of free hemoglobin and bilirubin on heparin monitoring by activated partial thromboplastin time and anti-Xa assay.
    Kostousov V; Nguyen K; Hundalani SG; Teruya J
    Arch Pathol Lab Med; 2014 Nov; 138(11):1503-6. PubMed ID: 25357112
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of an enzymatically depolymerized heparin as compared with conventional heparin in healthy volunteers.
    Mätzsch T; Bergqvist D; Hedner U; Ostergaard P
    Thromb Haemost; 1987 Feb; 57(1):97-101. PubMed ID: 3590085
    [TBL] [Abstract][Full Text] [Related]  

  • 24. An improved heparin assay which is insensitive to platelet factor 4.
    Fickenscher K; Buckler U
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1989; 116(6):873-8. PubMed ID: 2483705
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Elevated activated partial thromboplastin time does not correlate with heparin rebound following cardiac surgery.
    Taneja R; Marwaha G; Sinha P; Quantz M; Stitt L; Gao R; Subramanian S; Schaus M; Keeney M; Chin-Yee I; Murkin J
    Can J Anaesth; 2009 Jul; 56(7):489-96. PubMed ID: 19408066
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The effect of calcium ions on the activated partial thromboplastin time of heparinized plasma.
    Greenberg CS; Adams JP; Mullen PE; Koepke JA
    Am J Clin Pathol; 1986 Oct; 86(4):484-9. PubMed ID: 3766461
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparison of anticoagulant and anti-inflammatory responses using enoxaparin versus unfractionated heparin for transesophageal echocardiography-guided cardioversion of atrial fibrillation.
    Hoppensteadt D; Fareed J; Klein AL; Jasper SE; Apperson-Hansen C; Lieber EA; Katz WE; Malouf JF; Stoddard MF; Pape LA;
    Am J Cardiol; 2008 Oct; 102(7):842-6. PubMed ID: 18805108
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Heparin binding to plasma proteins, an important mechanism for heparin resistance.
    Young E; Prins M; Levine MN; Hirsh J
    Thromb Haemost; 1992 Jun; 67(6):639-43. PubMed ID: 1509402
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Anti-factor Xa plasma levels in pregnant women receiving low molecular weight heparin thromboprophylaxis.
    Fox NS; Laughon SK; Bender SD; Saltzman DH; Rebarber A
    Obstet Gynecol; 2008 Oct; 112(4):884-9. PubMed ID: 18827132
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Heparin assay in plasma. Comparison of different methods (author's transl)].
    Vinazzer H
    Anaesthesist; 1979 Jun; 28(6):299-303. PubMed ID: 464252
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparative performance of three anti-factor Xa heparin assays in patients in a medical intensive care unit receiving intravenous, unfractionated heparin.
    Lehman CM; Rettmann JA; Wilson LW; Markewitz BA
    Am J Clin Pathol; 2006 Sep; 126(3):416-21. PubMed ID: 16880140
    [TBL] [Abstract][Full Text] [Related]  

  • 32. In vitro effects of detergent sclerosants on antithrombotic mechanisms.
    Parsi K; Exner T; Low J; Ma DD; Joseph JE
    Eur J Vasc Endovasc Surg; 2009 Aug; 38(2):220-8. PubMed ID: 19442540
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Standard assays underestimate the concentration of heparin in neonatal plasma.
    Schmidt B; Mitchell L; Ofosu F; Andrew M
    J Lab Clin Med; 1988 Nov; 112(5):641-3. PubMed ID: 3183496
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The APTT monitoring of heparin--the ISTH/ICSH collaborative study.
    Van der Velde EA; Poller L
    Thromb Haemost; 1995 Jan; 73(1):73-81. PubMed ID: 7740500
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Age-related plasma reference ranges for two heparin-binding proteins--vitronectin and platelet factor 4.
    Newall F; Johnston L; Ignjatovic V; Summerhayes R; Monagle P
    Int J Lab Hematol; 2009 Dec; 31(6):683-7. PubMed ID: 19909382
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Interlaboratory variation in heparin monitoring: Lessons from the Quality Management Program of Ontario coagulation surveys.
    Cuker A; Raby A; Moffat KA; Flynn G; Crowther MA
    Thromb Haemost; 2010 Oct; 104(4):837-44. PubMed ID: 20664895
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Automatization of heparin determination using chronometric evaluation of anti-Xa activity of the AT III-heparin complex].
    Sampol J; Rossi JM; Lejay G
    Ann Biol Clin (Paris); 1984; 42(1):21-3. PubMed ID: 6731952
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Conventional chromogenic heparin assays are influenced by patient's endogenous plasma Antithrombin levels.
    Mitchell LG; Vegh P
    Klin Padiatr; 2010 May; 222(3):164-7. PubMed ID: 20514621
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Heparin/heparan sulfate anticoagulant glycosaminoglycans in human plasma of healthy donors: preliminary study on a small group of recruits.
    Cecchi F; Pacini S; Gulisano M; Macchi C; Catini C; Lova RM; Fuzzi G; Ruggiero M; Vannucchi S
    Blood Coagul Fibrinolysis; 2008 Jul; 19(5):349-54. PubMed ID: 18600081
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Synthesis and bioactivity of copolymers with fragments of heparin.
    Mazid MA; Moase E; Scott E; Hanna HR; Unger FM
    J Biomed Mater Res; 1991 Sep; 25(9):1169-81. PubMed ID: 1779000
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.